for $2.8 billion in cash and stock. The deal will strengthen Exact Sciences' lineup of cancer testing products.
Exact Sciences also issued its quarterly numbers this morning, losing 30 cents per share compared to a consensus estimate of a 56 cent loss. The maker of the Cologuard colon cancer test also reported revenue that exceeded Street forecasts.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
When Media 'report' the market are they trying to influence it? Much like other public opinions.
Buying Biotech all day today!
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Source: WSJ - 🏆 98. / 63 Read more »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Seriously can we STOP all the mega mergers Mylan was the one that increased the compensation of CEO HeatherBresch (daughter of FakeDem JoeManchin) 600% while jacking up the price of the lifesaving Epipen 400%.
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer and Mylan reportedly near merger deal for low-priced drugsOne company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. You went crazy over sprint and t-mobile yesterday but this is a big win ? This proves beyond a shadow of a doubt where your priorities lays. Not a peep out of democrats and you reporting it as a good deal. This is a shame. This is why we have President Trump. Nonononononononono Hmmm, with lesser competition, it's easier for big corporations to dictate and control prices. I hope this low-price drug market goal is going to happen.
Source: CNN - 🏆 4. / 95 Read more »
Pfizer plans combination of off-patent drug business with MylanThe deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.
Source: CNBC - 🏆 12. / 72 Read more »
Asia stocks set to trade lower as US-China trade talks resumeStocks in Asia were set to trade lower on Monday as U.S.-China talks resume in Beijing later this week amid low expectations for a major breakthrough. All fighting for market in africa
Source: CNBC - 🏆 12. / 72 Read more »